Bagsværd, Denmark, 5 February 2019 - Novo Nordisk A/S has filed its Annual Report 2018 on Form 20-F for the financial year 2018 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2018. The reports are available at the SEC's website, www.sec.gov (http://www.sec.gov/index.htm), as well as on novonordisk.com (http://www.novonordisk.com/annualreport).
Shareholders and ADR holders may receive a hard copy of the annual reports free of charge upon request by filling out a request form on novonordisk.com (http://www.novonordisk.com/annualreport) or upon request to chqt@novonordisk.com (mailto:chqt@novonordisk.com) - please state the exact mailing address and the document(s) you wish to receive.
Further information
| Media: | ||
| Mette Kruse Danielsen | +45 4442 3883 | mkd@novonordisk.com (mailto:mkd@novonordisk.com) |
| Ken Inchausti (US) | +1 609 786 8316 | kiau@novonordisk.com (mailto:mailtokiau@novonordisk.com) |
| Investors: | ||
| Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com (mailto:phak@novonordisk.com) |
| Anders Mikkelsen | +45 3079 4461 | armk@novonordisk.com (mailto:armk@novonordisk.com) |
| Valdemar Borum Svarrer | +45 3079 0301 | jvls@novonordisk.com (mailto:jvls@novonordisk.com) |
| Kristoffer Due Berg | +45 3079 2849 | krdb@novonordisk.com (mailto:krdb@novonordisk.com) |
| Ann Søndermølle Rendbæk | +45 3075 2253 | arnd@novonordisk.com (mailto:arnd@novonordisk.com) |
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
